Stay updated on Fasinumab Long-Term Safety in OA Clinical Trial
Sign up to get notified when there's something new on the Fasinumab Long-Term Safety in OA Clinical Trial page.

Latest updates to the Fasinumab Long-Term Safety in OA Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.3 is displayed, replacing Revision: v3.4.2 on the page.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added and the prior funding-status notice (v3.4.1) text was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedA site-wide notice about government funding lapse and NIH operating status was added. The site version was updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check48 days agoChange DetectedAdded Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page revision history was updated: added Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedLocations now lists many new sites across the U.S. and internationally (Alabama, Arizona, Arkansas, California, Colorado, Florida, Georgia, Illinois, Kansas, Maryland, Massachusetts, Minnesota, Missouri, Nebraska, Nevada, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Texas, Saxony, Baja California, Jalisco, Mexico City, Morelos, Sinaloa, Yucatán, Gauteng, Skåne County). The previous list of locations has been replaced.SummaryDifference1%

Stay in the know with updates to Fasinumab Long-Term Safety in OA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fasinumab Long-Term Safety in OA Clinical Trial page.